scPharmaceuticals Inc. Profile Avatar - Palmy Investing

scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through…

Biotechnology
US, Burlington [HQ]

Earnings Call Transcripts

Could not find a transcript
End of SCPH's Analysis
CIK: 1604950 CUSIP: 810648105 ISIN: US8106481059 LEI: - UEI: -
Secondary Listings
SCPH has no secondary listings inside our databases.